SCHH vs XBI
Schwab US REIT ETF vs SPDR S&P Biotech ETF
SCHH—
Schwab US REIT ETF
US REITs at very low cost.
Expense: —Yield: —
XBI—
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: —Yield: —
Side-by-side metrics
| Metric | SCHH | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | Schwab | State Street |
SCHH top holdings
Holdings data unavailable for SCHH.
XBI top holdings
Holdings data unavailable for XBI.
About SCHH
SCHH (Schwab US REIT ETF) is US REITs at very low cost.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index.